Mar 6, 2019
Dr. Dan Alkon, President and Chief Scientific Officer, Neurotrope is an internationally recognized pioneer in research on brain based neural networks, the molecular basis of memory and degenerative brain disorders. Neurotrope has seen very promising results in clinical trials with Bryostatin-1 with patients with advanced Alzheimer's disease, in many cases reversing the damage done to synapses and improving memory. They are on the path to attacking the progression of Alzheimer's and not just treating the symptoms.
#neurotrope #alzheimersdisease #alzheimers #biotechnology #biotech #pharma
@Neurotrope1